Adaptimmune Therapeutics plc (ADAP) Social Stream
ADAPTIMMUNE THERAPEUTICS PLC (ADAP) Price Targets From Analysts
Use the tables below to see what analysts covering ADAPTIMMUNE THERAPEUTICS PLC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-01-14 | 5 | $17 | $7 | $10.333 | $0.509 | 1930.06% |
| 2022-02-23 | 5 | $9 | $7 | $7.666 | $0.509 | 1406.09% |
| 2022-03-14 | 5 | $9 | $3 | $6.333 | $0.509 | 1144.2% |
| 2022-05-17 | 5 | $9 | $2 | $6 | $0.509 | 1078.78% |
| 2022-08-04 | 4 | $9 | $2 | $6 | $0.509 | 1078.78% |
| 2022-09-09 | 4 | $10 | $2 | $6 | $0.509 | 1078.78% |
| 2022-10-04 | 4 | $10 | $1.5 | $4.5 | $0.509 | 784.09% |
| 2022-11-09 | 5 | $10 | $1.5 | $5.875 | $0.509 | 1054.22% |
| 2022-11-14 | 6 | $10 | $3 | $6.25 | $0.509 | 1127.9% |
| 2023-01-05 | 7 | $10 | $3 | $6.666 | $0.509 | 1209.63% |
| 2023-03-06 | 6 | $10 | $3 | $6 | $0.509 | 1078.78% |
| 2023-05-12 | 6 | $10 | $2 | $5.8 | $0.509 | 1039.49% |
| 2023-08-10 | 7 | $10 | $1 | $5 | $0.509 | 882.32% |
| 2023-11-08 | 7 | $10 | $1 | $4.833 | $0.509 | 849.51% |
The Trend in the Analyst Price Target
ADAP's average price target has moved down $2.83 over the prior 21 months.
Over the past 44 weeks, ADAP's average upside potential has been 412.72%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-05 | 6 | 10 | 3 | 6.666 | 2.040 | 226.76% |
| 2023-03-06 | 6 | 10 | 2 | 5.800 | 1.320 | 339.39% |
| 2023-04-11 | 6 | 10 | 2 | 5.800 | 1.210 | 379.34% |
| 2023-05-12 | 6 | 10 | 2 | 5.800 | 1.370 | 323.36% |
| 2023-08-10 | 7 | 10 | 1 | 5.000 | 0.815 | 513.5% |
ADAP Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.14 | 4 | 0 | 2 | 1 | 1 | 7 |
The Trend in the Broker Recommendations
Over the past 13 months, ADAP's average broker recommendation rating worsened by 0.14.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- ADAP has a greater upside potential (average analyst target price relative to current price) than 1746.31% of all US stocks.
- ADAP has a higher average analyst price target than 101.39% of all US stocks.
- ADAPTIMMUNE THERAPEUTICS PLC's variance in analysts' estimates is lower than -1508.9% of all US stocks.
- ADAP has a higher number of analysts covering the stock than 491.44% of Healthcare stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to ADAPTIMMUNE THERAPEUTICS PLC are OTLK, TTNP, and BCDA.
View All Top Stocks by Price Target
Make investment decisions regarding ADAP using the data that counts. Try POWR Ratings for free.